pTargeT (linearized)

Linearized TA cloning vector with 3'-T overhangs for expressing PCR-amplified genes in mammalian cells.

Sequence Author: Promega

|Download SnapGene Viewer
Explore Over 2.7k Plasmids: TA and GC Cloning Vectors | More Plasmid Sets
No matches
BglII (4382) AlwNI (3961) AhdI (3482) BpmI (3413) ScaI (3001) XmnI (2882) EcoO109I (2502) PfoI (2443) BstXI (2241) BstBI (2202) RsrII (2036) BssHII (1917) PflFI - Tth111I (1638) BbeI (1523) SfoI (1521) NarI (1520) KasI (1519) BsrGI (4483) SpeI (4539) CMV enhancer NdeI (4774) SnaBI (4880) AsiSI (5051) Eco53kI (5114) SacI (5116) BmgBI (5536) lacZα AanI (5615) EcoRI (5637) BamHI (5643) NheI (5651) BmtI (5655) PaeR7I - XhoI (5657) AflIII - MluI (5663) End (5672) Start (1) TspMI - XmaI (8) SmaI (10) Acc65I (14) KpnI (18) SalI (20) AccI (21) NotI (28) EcoRI (35) pTargeT™ Sequencing Primer (61 .. 84) lac operator AanI (361) HpaI (381) MfeI (390) BsaBI * (483) BspDI * - ClaI * (487) BspEI (492) PmlI (566) DraIII (747) AanI (872) SexAI * (1093) SfiI (1279) BseRI (1322) StuI (1325) AvrII (1326) pTargeT™ 5671 bp
BglII  (4382)
1 site
A G A T C T T C T A G A
AlwNI  (3961)
1 site
C A G N N N C T G G T C N N N G A C

Sticky ends from different AlwNI sites may not be compatible.
AhdI  (3482)
1 site
G A C N N N N N G T C C T G N N N N N C A G

The 1-base overhangs produced by AhdI may be hard to ligate.
Sticky ends from different AhdI sites may not be compatible.
BpmI  (3413)
1 site
C T G G A G ( N ) 14 N N G A C C T C ( N ) 14

Efficient cleavage requires at least two copies of the BpmI recognition sequence.
Sticky ends from different BpmI sites may not be compatible.
After cleavage, BpmI can remain bound to DNA and alter its electrophoretic mobility.
BpmI quickly loses activity at 37°C.
ScaI  (3001)
1 site
A G T A C T T C A T G A
XmnI  (2882)
1 site
G A A N N N N T T C C T T N N N N A A G
EcoO109I  (2502)
1 site
R G G N C C Y Y C C N G G R

Sticky ends from different EcoO109I sites may not be compatible.
PfoI  (2443)
1 site
T C C N G G A A G G N C C T

Sticky ends from different PfoI sites may not be compatible.
BstXI  (2241)
1 site
C C A N N N N N N T G G G G T N N N N N N A C C

Sticky ends from different BstXI sites may not be compatible.
BstBI  (2202)
1 site
T T C G A A A A G C T T
RsrII  (2036)
1 site
C G G W C C G G C C W G G C

Efficient cleavage requires at least two copies of the RsrII recognition sequence.
Sticky ends from different RsrII sites may not be compatible.
For full activity, add fresh DTT.
BssHII  (1917)
1 site
G C G C G C C G C G C G

BssHII is typically used at 50°C, but is 75% active at 37°C.
PflFI  (1638)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by PflFI may be hard to ligate.
Sticky ends from different PflFI sites may not be compatible.
Tth111I  (1638)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by Tth111I may be hard to ligate.
Sticky ends from different Tth111I sites may not be compatible.
BbeI  (1523)
1 site
G G C G C C C C G C G G

Cleavage may be enhanced when more than one copy of the BbeI recognition sequence is present.
SfoI  (1521)
1 site
G G C G C C C C G C G G
NarI  (1520)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the NarI recognition sequence.
KasI  (1519)
1 site
G G C G C C C C G C G G
BsrGI  (4483)
1 site
T G T A C A A C A T G T

BsrGI is typically used at 37°C, but is even more active at 60°C.
SpeI  (4539)
1 site
A C T A G T T G A T C A
NdeI  (4774)
1 site
C A T A T G G T A T A C

Prolonged incubation with NdeI may lead to removal of additional nucleotides.
SnaBI  (4880)
1 site
T A C G T A A T G C A T
AsiSI  (5051)
1 site
G C G A T C G C C G C T A G C G
Eco53kI  (5114)
1 site
G A G C T C C T C G A G
SacI  (5116)
1 site
G A G C T C C T C G A G
BmgBI  (5536)
1 site
C A C G T C G T G C A G

This recognition sequence is asymmetric, so ligating blunt ends generated by BmgBI will not always regenerate a BmgBI site.
AanI  (5615)
3 sites
T T A T A A A A T A T T
EcoRI  (5637)
2 sites
G A A T T C C T T A A G
BamHI  (5643)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF® (but not the original BamHI) can remain bound to DNA and alter its electrophoretic mobility.
NheI  (5651)
1 site
G C T A G C C G A T C G
BmtI  (5655)
1 site
G C T A G C C G A T C G
PaeR7I  (5657)
1 site
C T C G A G G A G C T C

PaeR7I does not recognize the sequence CTCTCGAG.
XhoI  (5657)
1 site
C T C G A G G A G C T C
AflIII  (5663)
1 site
A C R Y G T T G Y R C A

Sticky ends from different AflIII sites may not be compatible.
MluI  (5663)
1 site
A C G C G T T G C G C A
End  (5672)
0 sites
Start  (1)
0 sites
TspMI  (8)
1 site
C C C G G G G G G C C C
XmaI  (8)
1 site
C C C G G G G G G C C C

Cleavage may be enhanced when more than one copy of the XmaI recognition sequence is present.
SmaI  (10)
1 site
C C C G G G G G G C C C

SmaI can be used at 37°C for brief incubations.
Acc65I  (14)
1 site
G G T A C C C C A T G G
KpnI  (18)
1 site
G G T A C C C C A T G G
SalI  (20)
1 site
G T C G A C C A G C T G
AccI  (21)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the recognition sequence.
Sticky ends from different AccI sites may not be compatible.
NotI  (28)
1 site
G C G G C C G C C G C C G G C G
EcoRI  (35)
2 sites
G A A T T C C T T A A G
AanI  (361)
3 sites
T T A T A A A A T A T T
HpaI  (381)
1 site
G T T A A C C A A T T G
MfeI  (390)
1 site
C A A T T G G T T A A C
BsaBI  (483)
1 site
G A T N N N N A T C C T A N N N N T A G
* Blocked by Dam methylation.
BspDI  (487)
1 site
A T C G A T T A G C T A
* Blocked by Dam methylation.
ClaI  (487)
1 site
A T C G A T T A G C T A
* Blocked by Dam methylation.
BspEI  (492)
1 site
T C C G G A A G G C C T
PmlI  (566)
1 site
C A C G T G G T G C A C
DraIII  (747)
1 site
C A C N N N G T G G T G N N N C A C

Sticky ends from different DraIII sites may not be compatible.
AanI  (872)
3 sites
T T A T A A A A T A T T
SexAI  (1093)
1 site
A C C W G G T T G G W C C A
* Blocked by Dcm methylation.
Sticky ends from different SexAI sites may not be compatible.
SfiI  (1279)
1 site
G G C C N N N N N G G C C C C G G N N N N N C C G G

Efficient cleavage requires at least two copies of the SfiI recognition sequence.
Sticky ends from different SfiI sites may not be compatible.
BseRI  (1322)
1 site
G A G G A G ( N ) 8 N N C T C C T C ( N ) 8

Sticky ends from different BseRI sites may not be compatible.
BseRI quickly loses activity at 37°C.
Prolonged incubation with BseRI may lead to degradation of the DNA.
StuI  (1325)
1 site
A G G C C T T C C G G A
AvrII  (1326)
1 site
C C T A G G G G A T C C
pTargeT™ Sequencing Primer
24-mer  /  38% GC
1 binding site
61 .. 84  =  24 annealed bases
Tm  =  55°C
AmpR
2695 .. 3555  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
   Segment 1:  signal sequence  
   2695 .. 2763  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
2695 .. 3555  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
   Segment 2:  
   2764 .. 3555  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
2695 .. 3555  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
NeoR/KanR
1392 .. 2186  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from Tn5
confers resistance to neomycin, kanamycin, and G418 (Geneticin)
NeoR/KanR
1392 .. 2186  =  795 bp
264 amino acids  =  29.0 kDa
Product: aminoglycoside phosphotransferase from Tn5
confers resistance to neomycin, kanamycin, and G418 (Geneticin)
ori
3726 .. 4314  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
ori
3726 .. 4314  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
f1 ori
515 .. 969  =  455 bp
f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis
f1 ori
515 .. 969  =  455 bp
f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis
SV40 promoter
984 .. 1341  =  358 bp
SV40 enhancer and early promoter
SV40 promoter
984 .. 1341  =  358 bp
SV40 enhancer and early promoter
CMV enhancer
4600 .. 4904  =  305 bp
human cytomegalovirus immediate early enhancer
CMV enhancer
4600 .. 4904  =  305 bp
human cytomegalovirus immediate early enhancer
lacZα
5438 .. 5671  =  234 bp
77 amino acids  =  9.0 kDa
Product: LacZα fragment of β-galactosidase
lacZα
5438 .. 5671  =  234 bp
77 amino acids  =  9.0 kDa
Product: LacZα fragment of β-galactosidase
CMV promoter
4905 .. 5116  =  212 bp
human cytomegalovirus (CMV) immediate early promoter
CMV promoter
4905 .. 5116  =  212 bp
human cytomegalovirus (CMV) immediate early promoter
chimeric intron
5277 .. 5409  =  133 bp
chimera between introns from human β-globin and immunoglobulin heavy chain genes
chimeric intron
5277 .. 5409  =  133 bp
chimera between introns from human β-globin and immunoglobulin heavy chain genes
SV40 poly(A) signal
260 .. 381  =  122 bp
SV40 polyadenylation signal
SV40 poly(A) signal
260 .. 381  =  122 bp
SV40 polyadenylation signal
AmpR promoter
2590 .. 2694  =  105 bp
AmpR promoter
2590 .. 2694  =  105 bp
lacZα
2 .. 94  =  93 bp
31 amino acids  =  3.3 kDa
Product: LacZα fragment of β-galactosidase
lacZα
2 .. 94  =  93 bp
31 amino acids  =  3.3 kDa
Product: LacZα fragment of β-galactosidase
poly(A) signal
2250 .. 2298  =  49 bp
synthetic polyadenylation signal
poly(A) signal
2250 .. 2298  =  49 bp
synthetic polyadenylation signal
lac promoter
138 .. 168  =  31 bp
3 segments
   Segment 3:  -10  
   138 .. 144  =  7 bp
promoter for the E. coli lac operon
lac promoter
138 .. 168  =  31 bp
3 segments
   Segment 2:  
   145 .. 162  =  18 bp
promoter for the E. coli lac operon
lac promoter
138 .. 168  =  31 bp
3 segments
   Segment 1:  -35  
   163 .. 168  =  6 bp
promoter for the E. coli lac operon
lac promoter
138 .. 168  =  31 bp
3 segments
promoter for the E. coli lac operon
lac operator
114 .. 130  =  17 bp
The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-β-D-thiogalactopyranoside (IPTG).
lac operator
114 .. 130  =  17 bp
The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-β-D-thiogalactopyranoside (IPTG).
SV40 ori
1192 .. 1327  =  136 bp
SV40 origin of replication
SV40 ori
1192 .. 1327  =  136 bp
SV40 origin of replication
MCS
2 .. 40  =  39 bp
multiple cloning site
MCS
2 .. 40  =  39 bp
multiple cloning site
MCS
5637 .. 5671  =  35 bp
multiple cloning site
MCS
5637 .. 5671  =  35 bp
multiple cloning site
T7 promoter
5616 .. 5634  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T7 promoter
5616 .. 5634  =  19 bp
promoter for bacteriophage T7 RNA polymerase
ORF:  1564 .. 1950  =  387 bp
ORF:  128 amino acids  =  14.6 kDa
ORF:  2695 .. 3555  =  861 bp
ORF:  286 amino acids  =  31.6 kDa
ORF:  1392 .. 2186  =  795 bp
ORF:  264 amino acids  =  29.0 kDa
ORF:  1701 .. 2237  =  537 bp
ORF:  178 amino acids  =  19.8 kDa
ORF:  3159 .. 3425  =  267 bp
ORF:  88 amino acids  =  9.2 kDa
ORF:  5438 .. 5671  =  234 bp
ORF:  77 amino acids  =  9.0 kDa  (no start codon)
Click here to try SnapGene

Download pTargeT (linearized).dna file

SnapGene

SnapGene is the easiest way to plan, visualize and document your everyday molecular biology procedures

  • Fast accurate construct design for all major molecular cloning techniques
  • Validate sequenced constructs using powerful alignment tools
  • Customize plasmid maps with flexible annotation and visualization controls
  • Automatically generate a rich graphical history of every edit and procedure

SnapGene Viewer

SnapGene Viewer is free software that allows molecular biologists to create, browse, and share richly annotated sequence files.

  • Gain unparalleled visibility of your plasmids, DNA and protein sequences
  • Annotate features on your plasmids using the curated feature database
  • Store, search, and share your sequences, files and maps

Individual Sequences & Maps

The maps, notes, and annotations in the zip file on this page are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as ’’www.snapgene.com/resources’’. Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Discover the most user-friendly molecular biology experience.